OUR TEAM

  • 4BIO Capital is a unique team of passionate academics, physician-scientists, industry executives and investment professionals that have come together to address the challenge of chronic disease through early-stage investment in advanced therapies

 

  • With in-depth understanding being the key to success in the rapidly developing therapeutic landscape, 4BIO only invests in advanced therapies, offering investors undiluted access to the fastest growing field of medicine

 

  • The team have not only backed successful advanced therapy companies, but have also contributed to the scientific progress of the field through their own bench research

 

  • 4BIO scientific advisory board includes founders of gene therapy field in academic and hospital settings, leading groups in world centres of academic and clinical excellence

VENTURE PARTNER, JAPAN
PHILIPPE FAUCHET OBE
DIRECTOR, OPERATIONS
VASILY FEDORIN PhD
  • White LinkedIn Icon
  • White LinkedIn Icon
INVESTMENT ANALYST
NATALIE JOHNSTON PhD
MANAGING PARTNER
ANDREW KOZLOV MBA
  • White LinkedIn Icon
VENTURE PARTNER, USA
YURY KUKUSHKIN PhD
  • White LinkedIn Icon
MANAGING PARTNER
DIMA KUZMIN PhD
  • White LinkedIn Icon
VENTURE PARTNER, USA
BRIAN MCVEIGH MBA
  • White LinkedIn Icon
PARTNER
KIERAN MUDRYY
  • White LinkedIn Icon
NON-EXECUTIVE DIRECTOR
LORCAN MURPHY
  • White LinkedIn Icon
OFFICE MANAGER 
SUNYARA PEREZ
  • White LinkedIn Icon
  • White LinkedIn Icon
RESEARCH ANALYST
MARIA SHUTOVA PhD
OWEN SMITH
  • White LinkedIn Icon
DIRECTOR, INVESTMENT
ADVISORY BOARD
PROF. DIMITRI M
KULLMANN FRCP
​Professor of Neurology,
UCL; Consultant Neurologist, NHNN
ADVISOR
CLIVE STANWAY PhD
CSO, Cancer Research Technology; Board Member, Spirogen
ADVISOR
ADVISOR
JOHANNES van der LOO PhD
Adj. Ass. Prof., UPenn School of Medicine; Director, Clinical Vector Core, The Children's Hospital of Philadelphia
PROF. ADRIAN THRASHER FRCP
ADVISOR
Professor of Paediatric 
Immunology, Wellcome Trust Principal Research Fellow,
UCL Institute of Child Health
CHARLIE METCALFE
Founder & Managing Director,
Wilton Real Estate Capital;
30+ years in investment banking
ADVISOR
KENYA HONDA MD PhD
Prof., Department of Microbiology and Immunology at Keio Univ. School of Medicine; Scientific Co-Founder, Vedanta Biosciences
ADVISOR
4BIO CAPITAL is a trade name of 4BIO Ventures Management Ltd, which is authorised and regulated by the Financial Conduct Authority, register number 775193
© 2015-2020 by 4BIO Ventures Management Ltd